Evidence map›Paper›PMID 30958165›Full record

ArticleJournal of the Royal Society, Interface2019

Assessing the airborne survival of bacteria in populations of aerosol droplets with a novel technology.

Mara Otero Fernandez, Richard J Thomas, Natalie J Garton, Andrew Hudson, Allen Haddrell, Jonathan P Reid

Abstract read
In one paragraph

Article in Journal of the Royal Society, Interface, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Mechanisms of bacterial host-to-host transmission.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  2. Article
  3. Article
  4. Influence of COAntibiotics (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. The microphysics of surrogates of exhaled aerosols from the upper respiratory tract.Aerosol science and technology : the journal of the American Association for Aerosol Research · 2024
    Article
  9. Complete reference genome assemblies and annotations of threeMicrobiology resource announcements · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Review
  15. Article
  16. Survival ofAnimals : an open access journal from MDPI · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mara Otero Fernandez1 School of Chemistry, University of Bristol , Bristol BS8 1TS , UK.
Richard J Thomas2 Defence Science Technology Laboratory (DSTL) , Porton Down, Salisbury SP4 0JQ , UK.
Natalie J Garton3 Department of Infection, Immunity and Inflammation, University of Leicester , Leicester LE1 7RH , UK.
Andrew Hudson4 Department of Chemistry, Leicester Institute of Structural and Chemical Biology, University of Leicester , Leicester LE1 7RH , UK.
Allen Haddrell1 School of Chemistry, University of Bristol , Bristol BS8 1TS , UK.
Jonathan P Reid1 School of Chemistry, University of Bristol , Bristol BS8 1TS , UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The airborne transmission of infection relies on the ability of pathogens to survive aerosol transport as they transit between hosts. Understanding the parameters that determine the survival of airborne microorganisms is critical to mitigating the impact of disease outbreaks. Conventional techniques for investigating bioaerosol longevity in vitro have systemic limitations that prevent the accurate representation of conditions that these particles would experience in the natural environment. Here, we report a new approach that enables the robust study of bioaerosol survival as a function of relevant environmental conditions. The methodology uses droplet-on-demand technology for the generation of bioaerosol droplets (1 to greater than 100 per trial) with tailored chemical and biological composition. These arrays of droplets are captured in an electrodynamic trap and levitated within a controlled environmental chamber. Droplets are then deposited on a substrate after a desired levitation period (less than 5 s to greater than 24 h). The response of bacteria to aerosolization can subsequently be determined by counting colony forming units, 24 h after deposition. In a first study, droplets formed from a suspension of Escherichia coli MRE162 cells (10

Indexed as

Microbial ViabilityModels, BiologicalAerosolsEscherichia coliAerosolsaerosol transportairborne transmissionbioaerosolinfectionsurvival

Identifiers

PMID30958165
PMCPMC6364649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.